Maze Therapeutics, Inc. (MAZE) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $354.97M | +214.1% |
| 2024 | -$311.18M | +16.8% |
| 2023 | -$373.85M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $354.97M | +214.1% |
| 2024 | -$311.18M | +16.8% |
| 2023 | -$373.85M | — |